Document is current
Any future updates will be listed below
-
Authors
Gujarathi, Rushabh
Belmont, Erika
Rodman, Christopher
Bansal, Varun Vivek
Setia, Namrata
Alpert, Lindsay
Hart, John
Möller, Mecker G.
Eng, Oliver S.
Lee, Grace
Chin, Janet
Amin, Manik A.
Polite, Blase N.
Liao, Chih-Yi
Turaga, Kiran K.
Shergill, Ardaman
- License Information
-
More Information
Article History
Received: 24 October 2025
Accepted: 11 May 2026
First Online: 6 June 2026
Disclosure
: Lindsay Alpert: consultancy for Exact Sciences. Andy (Chih-Yi) Liao: received honoraria from AstraZeneca, Exelixis, Genentech, Histosonics, Incyte, Ipsen, QED, Transthera, Boston Scientific, Taiho, and Exelixis. Ardaman Shergill: advising and consultancy for Natera, Merus, Takeda, Ipson, Guardant, Pfizer, Amgen, Revolution Medicine, Iterion Therapeutics, Adcendo, and Abbvie; research (to institution): hutchison MediPharma/Takeda, Merck, Verastem Oncology, Turning Point Therapeutics, Gritstone, Bolt Therapeutics, BMS, Pfizer, Astellas, Oncologie, Macogenics, Seattle Genetics, Amgen, Daiichi, Eli Lilly, AstraZeneca, Genentech, Jazz Pharma, Abbvie, and Revmed; and travel: cure CRC Summit, Great Debates, OncLive, OSCO, ASCO, ACPMP, Cholangiocarcinoma Summit, Cholangiocarcinoma Foundation, ASCO Advantage, and Takeda for AACR poster.
